Stem Cell Banking via Optimized Culture Medium

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for culturing mesenchymal stem cells (MSCs) lead to premature senescence and decreased proliferative potential during prolonged culture, making it challenging to maintain their characteristics and achieve large batches of homogenous stem cells for therapeutic use.

Innovation Solution

A specific growth medium comprising serum, fibroblast growth factor, L-cysteine, glutathione, and other optional components is used to culture MSCs, allowing for multiple generations of stem cell cultures that remain morphologically identical and indistinguishable from the original, thereby enabling banking and maintaining a virtually unlimited supply of stem cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If current culturing methods are used to expand MSCs, then large batches of stem cells can be obtained, but the cells undergo premature senescence and lose their characteristic properties

Engineering Contradiction:
Improvebatch size of stem cellsVSAvoidmaintenance of stem cell characteristics
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the culture medium composition to include specific growth factors (b-FGF, VEGF, HGF, PDGF, EGF) and cytokines at optimized concentrations. This changes the chemical parameters of the culture environment to support prolonged stem cell proliferation while maintaining their undifferentiated state and characteristic properties, thereby resolving the contradiction between expanding batch size and maintaining cell quality

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If stem cells are cultured for prolonged periods to generate large batches, then therapeutic quantities can be achieved, but proliferative potential continuously decreases

Engineering Contradiction:
Improvetherapeutic quantity of stem cellsVSAvoidproliferative potential
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent implements continuity of useful action by using a culture medium that continuously supplies essential growth factors and cytokines throughout the culturing process. This continuous nutritional and signaling support enables stem cells to maintain high proliferative potential over extended culture periods, allowing accumulation of therapeutic quantities without the usual decline in productivity

Inventive Principle:
Principle #20Continuity of useful action

3Adaptability or versatility

If multiple generations of stem cells are banked for on-demand use, then therapeutic availability is improved, but maintaining homogeneity across generations becomes challenging

Engineering Contradiction:
Improveon-demand therapeutic availabilityVSAvoidhomogeneity of stem cell batches
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent applies the copying principle by using a standardized, optimized culture medium formulation that can be consistently applied across multiple generations of stem cell expansion. This creates reliable replicas of the original stem cell population, ensuring that each generation copied through culture maintains the same characteristics and homogeneity as the source material, enabling on-demand production of identical therapeutic batches

Inventive Principle:
Principle #26Copying

Data Source

PatentUS10959425B2Method of banking stem cells
Publication Date: 2021.03.30 HOPE BIOSCIENCES LLC
  • US10959425B2 patent drawing
  • US10959425B2 patent drawing
  • US10959425B2 patent drawing

AI summary

A method of banking stem cells by harvesting stem cells from an individual and culturing the harvested stem cells to generate a P0 culture. The method includes storing a desired amount of P0 stem cells via cryopreservation and subculturing a portion of the P0 stem cells to generate a P1 culture. A desired amount of P1 stems cells can then be stored via cryopreservation and further generations can be stored as desired.